Case Study: a US biopharmaceutical company achieves drug substance and salt selection with Quotient Sciences

US Biopharmaceutical Company advances drug substance and salt screening with Quotient Sciences

A US biopharmaceutical company required drug substance development and a salt screen selection for its molecule. The customer engaged Quotient Sciences to address this challenge, seeking its expertise in manufacturing the drug substance and identifying a suitable, pharmaceutically acceptable salt form.

Quotient Sciences implemented a solution to manufacture the drug substance and conduct a comprehensive screen of potential salt forms. The project was successfully completed, delivering the necessary materials and data to support the customer's development process. The work performed by Quotient Sciences provided the client with a critical foundation for advancing their molecule.